Tela Bio Net Worth
Tela Bio Net Worth Breakdown | TELA |
Tela Bio Net Worth Analysis
Tela Bio's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Tela Bio's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Tela Bio's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Tela Bio's net worth analysis. One common approach is to calculate Tela Bio's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Tela Bio's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Tela Bio's net worth. This approach calculates the present value of Tela Bio's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Tela Bio's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Tela Bio's net worth. This involves comparing Tela Bio's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Tela Bio's net worth relative to its peers.
Enterprise Value |
|
To determine if Tela Bio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Tela Bio's net worth research are outlined below:
| Tela Bio had very high historical volatility over the last 90 days | |
| Tela Bio has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 58.45 M. Net Loss for the year was (46.66 M) with profit before overhead, payroll, taxes, and interest of 27.85 M. | |
| Tela Bio currently holds about 27.73 M in cash with (40.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.9. | |
| Latest headline from news.google.com: TELA Bio Set to Unveil Innovations at Piper Sandlers Premier Healthcare Conference - MyChesCo |
Tela Bio uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Tela Bio. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Tela Bio's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 19th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 19th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Tela Bio's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Tela Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Tela Bio backward and forwards among themselves. Tela Bio's institutional investor refers to the entity that pools money to purchase Tela Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Perkins Capital Management Inc | 2024-09-30 | 225.2 K | Bank Of Montreal | 2024-09-30 | 191.4 K | Bmo Capital Markets Corp. | 2024-09-30 | 191.4 K | Geode Capital Management, Llc | 2024-09-30 | 174.5 K | Millennium Management Llc | 2024-09-30 | 159.1 K | Renaissance Technologies Corp | 2024-09-30 | 148.9 K | Landscape Capital Management,llc | 2024-09-30 | 143.2 K | Gsa Capital Partners Llp | 2024-09-30 | 112.2 K | Marshall Wace Asset Management Ltd | 2024-09-30 | 106.8 K | Essex Woodlands Health Ventures | 2024-09-30 | 4.1 M | Aigh Capital Management, Llc | 2024-09-30 | 2.5 M |
Follow Tela Bio's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 123.68 M.Market Cap |
|
Project Tela Bio's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.61) | (0.65) | |
| Return On Capital Employed | (0.72) | (0.76) | |
| Return On Assets | (0.60) | (0.63) | |
| Return On Equity | (2.47) | (2.60) |
When accessing Tela Bio's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Tela Bio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Tela Bio's profitability and make more informed investment decisions.
Please note, the presentation of Tela Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Tela Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Tela Bio's management manipulating its earnings.
Evaluate Tela Bio's management efficiency
Tela Bio has return on total asset (ROA) of (0.4064) % which means that it has lost $0.4064 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.4204) %, meaning that it created substantial loss on money invested by shareholders. Tela Bio's management efficiency ratios could be used to measure how well Tela Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of December 2, 2024, Return On Tangible Assets is expected to decline to -0.65. In addition to that, Return On Capital Employed is expected to decline to -0.76. At present, Tela Bio's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 278.2 K, whereas Total Assets are forecasted to decline to about 63.7 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.83 | 0.87 | |
| Tangible Book Value Per Share | 0.73 | 0.77 | |
| Enterprise Value Over EBITDA | (3.59) | (3.77) | |
| Price Book Value Ratio | 8.02 | 4.30 | |
| Enterprise Value Multiple | (3.59) | (3.77) | |
| Price Fair Value | 8.02 | 4.30 | |
| Enterprise Value | 131.2 M | 104.1 M |
The decision-making processes within Tela Bio are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Enterprise Value Revenue 2.1546 | Revenue 68.6 M | Quarterly Revenue Growth 0.259 | Revenue Per Share 2.789 | Return On Equity (3.42) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tela Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tela Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tela Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Tela Bio Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
10Q | 8th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 29th of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Tela Bio Earnings per Share Projection vs Actual
Tela Bio Corporate Management
| Megan Smeykal | Corporate VP | Profile | |
| Taylor Ocasio | General Secretary | Profile | |
| Antony Koblish | President, Cofounder | Profile | |
| Louisa Smith | Investor Officer | Profile | |
| Skott Greenhalgh | Chief Officer | Profile | |
| Peter Murphy | Chief Officer | Profile | |
| Roberto JD | CFO COO | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tela Bio. If investors know Tela will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tela Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.69) | Revenue Per Share 2.789 | Quarterly Revenue Growth 0.259 | Return On Assets (0.41) | Return On Equity (3.42) |
The market value of Tela Bio is measured differently than its book value, which is the value of Tela that is recorded on the company's balance sheet. Investors also form their own opinion of Tela Bio's value that differs from its market value or its book value, called intrinsic value, which is Tela Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tela Bio's market value can be influenced by many factors that don't directly affect Tela Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tela Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tela Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tela Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.